EarliTec is a company that aims to make earlier identification and treatment for autism and related vulnerabilities accessible to children everywhere, focusing on clinically validated technologies that enable personalized treatment for each individual child.

EarliTec Diagnostics is making earlier identification and treatment for autism and related early childhood vulnerabilities accessible to children everywhere. EarliTec's flagship product, EarliPoint™, is FDA authorized to diagnose and assess autism in children ages 16-30 months old and is available now.

COM:EARLITECDX

EarliTec

Analysis Not Available